Endocrine Abstracts

Introduction: Insulin Dugludec is an ultra- long acting basal insulin. The management of diabetes in children is challenging due to the need of regularly injecting insulin, risk of hypoglycaemia, variation in the activity of different insulins available. Dugludec has a long half-life (25 hrs), lower variability and lasts 42 hours. Currently there are no guidelines or NICE recommendations advising the use of insulin dugludec in children with diabetes. Studies are few but have s...